Literature DB >> 10547393

Multiple clonal abnormalities in the bronchial epithelium of patients with lung cancer.

I W Park1, I I Wistuba, A Maitra, S Milchgrub, A K Virmani, J D Minna, A F Gazdar.   

Abstract

BACKGROUND: Several molecular changes, including loss of heterozygosity (i.e., deletion of one copy of allelic DNA sequences) and alterations in microsatellite DNA, have been detected early in the pathogenesis of lung cancer, even in histologically normal epithelium. In the bronchial epithelium of patients with lung cancer, we have determined the frequency, size, and patterns of molecularly abnormal clonal patches.
METHODS: We studied formalin-fixed, paraffin-embedded samples from 16 surgically resected lung carcinomas (five squamous cell carcinomas, four small-cell carcinomas, six adenocarcinomas, and one large-cell carcinoma). From each carcinoma, we microdissected foci (each containing about 200 cells) of tumor tissue and equivalent samples of histologically normal and abnormal epithelium. Furthermore, multiple discontinuous foci of bronchial epithelium were analyzed from methanol-fixed samples from three additional patients with lung cancer (two with squamous cell carcinoma and one with adenocarcinoma). We used two-step polymerase chain reaction-based assays involving 12 microsatellite markers at seven chromosomal regions frequently deleted in lung cancer.
RESULTS: Two hundred eighteen foci of nonmalignant bronchial epithelium (195 of histologically normal or slightly abnormal epithelium and 23 of dysplastic epithelium) were studied from the 19 surgically resected lobectomy specimens. Thirteen (68%) of the 19 specimens had at least one focus of bronchial epithelium with molecular changes. At least one molecular abnormality was detected in 32% of the 195 histologically normal or slightly abnormal foci and in 52% of the 23 dysplastic foci. Extrapolating from our two-dimensional analyses, we estimate that most clonal patches contain approximately 90 000 cells. Although, in a given individual, tumors appeared homogeneous with respect to molecular changes, the clonally altered patches of mildly abnormal epithelium were heterogeneous.
CONCLUSIONS: Our findings indicate that multiple small clonal or subclonal patches containing molecular abnormalities are present in normal or slightly abnormal bronchial epithelium of patients with lung cancer.

Entities:  

Mesh:

Year:  1999        PMID: 10547393     DOI: 10.1093/jnci/91.21.1863

Source DB:  PubMed          Journal:  J Natl Cancer Inst        ISSN: 0027-8874            Impact factor:   13.506


  24 in total

Review 1.  Pathogenesis of lung cancer: 100 year report.

Authors:  York E Miller
Journal:  Am J Respir Cell Mol Biol       Date:  2005-09       Impact factor: 6.914

Review 2.  Genomic signatures in non-small-cell lung cancer: targeting the targeted therapies.

Authors:  Holly K Dressman; Andrea Bild; Jennifer Garst; David Harpole; Anil Potti
Journal:  Curr Oncol Rep       Date:  2006-07       Impact factor: 5.075

Review 3.  Molecular targets for cancer chemoprevention.

Authors:  William N William; John V Heymach; Edward S Kim; Scott M Lippman
Journal:  Nat Rev Drug Discov       Date:  2009-03       Impact factor: 84.694

Review 4.  The Stem Cell Network model: clinical implications in cancer.

Authors:  Rubén Cabanillas; José L Llorente
Journal:  Eur Arch Otorhinolaryngol       Date:  2008-09-20       Impact factor: 2.503

5.  Preneoplasia of lung cancer.

Authors:  Adi F Gazdar; Elisabeth Brambilla
Journal:  Cancer Biomark       Date:  2010       Impact factor: 4.388

6.  Expression of several genes in the human chromosome 3p21.3 homozygous deletion region by an adenovirus vector results in tumor suppressor activities in vitro and in vivo.

Authors:  Lin Ji; Masahiko Nishizaki; Boning Gao; David Burbee; Masashi Kondo; Craig Kamibayashi; Kai Xu; Nancy Yen; E Neely Atkinson; Bingliang Fang; Michael I Lerman; Jack A Roth; John D Minna
Journal:  Cancer Res       Date:  2002-05-01       Impact factor: 12.701

7.  Airway basal cells of healthy smokers express an embryonic stem cell signature relevant to lung cancer.

Authors:  Renat Shaykhiev; Rui Wang; Rachel K Zwick; Neil R Hackett; Roland Leung; Malcolm A S Moore; Camelia S Sima; Ion Wa Chao; Robert J Downey; Yael Strulovici-Barel; Jacqueline Salit; Ronald G Crystal
Journal:  Stem Cells       Date:  2013-09       Impact factor: 6.277

Review 8.  Lung cancer. 9: Molecular biology of lung cancer: clinical implications.

Authors:  K M Fong; Y Sekido; A F Gazdar; J D Minna
Journal:  Thorax       Date:  2003-10       Impact factor: 9.139

9.  In vivo optical coherence tomography imaging of preinvasive bronchial lesions.

Authors:  Stephen Lam; Beau Standish; Corisande Baldwin; Annette McWilliams; Jean leRiche; Adi Gazdar; Alex I Vitkin; Victor Yang; Norihiko Ikeda; Calum MacAulay
Journal:  Clin Cancer Res       Date:  2008-04-01       Impact factor: 12.531

10.  Two-round coamplification at lower denaturation temperature-PCR (COLD-PCR)-based sanger sequencing identifies a novel spectrum of low-level mutations in lung adenocarcinoma.

Authors:  Jin Li; Coren A Milbury; Cheng Li; G Mike Makrigiorgos
Journal:  Hum Mutat       Date:  2009-11       Impact factor: 4.878

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.